Preparation And Storage
Recommended Assay Procedures
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).
Product Notices
- This antibody was developed for use in flow cytometry.
- The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been performed on all conjugate lots.
- Researchers should determine the optimal concentration of this reagent for their individual applications.
- An isotype control should be used at the same concentration as the antibody of interest.
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
- For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.
- BD Horizon Brilliant Violet 510 is covered by one or more of the following US patents: 8,575,303; 8,354,239.
Companion Products
The 587702 monoclonal antibody specifically recognizes the alternately-spliced variant 2 of CD97 (CD97 v2). CD97 is an N-glycosylated seven-span transmembrane protein that is encoded by Adgre5 (Adhesion G protein-coupled receptor E5) which belongs to the EGF-TM7 subfamily within the G-protein coupled receptor (GPCR) II family. Several CD97 isoforms have been described that have either three or four epidermal growth factor-like (EGF) domains in their N-terminal extracellular region. Compared with the longest form, CD97 v2 has a 94-amino acid deletion that results in the loss of the third EGF-like repeat. CD97 is expressed on monocytes, macrophages, T cells, B cell subsets, dendritic cells, granulocytes, hematopoietic stem cells and progenitor cells, and smooth muscle cells. Through its EGF domains, CD97 binds to glycophosphatidylinositol-linked CD55 that is also known as decay accelerating factor (DAF) and is involved in the regulation of complement activity. CD97 plays a role in angiogenesis, neutrophil migration, and host defense.
The antibody was conjugated to BD Horizon™ BV510 which is part of the BD Horizon Brilliant™ Violet family of dyes. With an Ex Max of 405-nm and Em Max at 510-nm, BD Horizon BV510 can be excited by the violet laser and detected in the BD Horizon V500 (525/50-nm) filter set. BD Horizon BV510 conjugates are useful for the detection of dim markers off the violet laser.
Development References (3)
-
Carver EA, Hamann J, Olsen AS, Stubbs L. Physical mapping of EMR1 and CD97 in human Chromosome 19 and assignment of Cd97 to mouse Chromosome 8 suggest an ancient genomic duplication.. Mamm Genome. 1999; 10(10):1039-40. (Biology). View Reference
-
Kwakkenbos MJ, Kop EN, Stacey M, et al. The EGF-TM7 family: a postgenomic view.. Immunogenetics. 2004; 55(10):655-66. (Biology). View Reference
-
Leemans JC, te Velde AA, Florquin S, et al. The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense. J Immunol. 2004, January; 172(2):1125-1131. (Biology). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
